Accidental injections of dexamethasone intravitreal implant (Ozurdex®) into the crystalline lens

European Journal of Ophthalmology

Volumn 24, Issue 4, 2014, Pages 633-636

  Coca Robinot, Javier ^a   Casco Silva, Bruno ^a   Armadá Maresca, Felix ^a   García Martínez, Jesús ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Cataract; Crystalline lens; Macular edema; Ozurdex ; Retinal vein occlusion

Indexed keywords

ANTIHYPERTENSIVE AGENT; BEVACIZUMAB; BRIMONIDINE PLUS TIMOLOL; BRINZOLAMIDE; BRINZOLAMIDE PLUS TIMOLOL; DEXAMETHASONE; TIMOLOL;

ACCIDENT; AGED; ARTICLE; CASE REPORT; CATARACT; CATARACT EXTRACTION; DRUG IMPLANT; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LENS CAPSULE RUPTURE; LENS DISEASE; MALE; MEDICAL PARAMETERS; OPTICAL COHERENCE TOMOGRAPHY; PHACOFRAGMENTATION PARAMETERS; PRIORITY JOURNAL; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; VERY ELDERLY; VISUAL ACUITY; VITRECTOMY;

AGED; AGED, 80 AND OVER; CATARACT EXTRACTION; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; LENS, CRYSTALLINE; MACULAR EDEMA; MALE; RETINAL VEIN OCCLUSION; VISUAL ACUITY; VITRECTOMY;

EID: 84903174442     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/ejo.5000439     Document Type: Article

References (9)

1. Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE. Macular edema. Surv Ophthalmol 2004;49:470-90.
2. Haller JA, Bandello F, Belfort R Jr, et al; Ozurdex Geneva Study Group. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 2011;118:2453-60.
3. Cavalcante LL, Cavalacante M. Murray TG, et al. Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis. Clin Ophthalmol 2010;25:519-24.
4. Koller S, Neuhann T, Neuhann I. [Conspicuous crystalline lens foreign body after intravitreal injection.] Ophthalmologe 2012;109:1119-21.
5. Ram J, Agarwal AK, Gupta A, et al. Phacoemulsification and intraocular lens implantation after inadvertent intracapsularinjection of intravitreal dexamethasone implant. BMJ Case Rep 2012;12:PAGINAS.
6. Ip MS, Scott IU, VanVeldhuisen PC, et al; SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009;127: 1101-14.
7. Kuno N, Fujii S. Biodegradable intraocular therapies for retinal disorders: progress to date. Drugs Aging 2010;27: 117-34.
8. Riordan-Eva P. Vaughan & Asbury's General Ophthalmology, 16th ed. New York: McGraw-Hill; 2007.
9. Yeh WS, Haller JA, Lanzetta P, et al. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology 2012;119:1190-8.